Arizona Tribune - Redwood AI Exploring Opportunities for its Proprietary AI Platform Across Multiple Industries

This emerging cross-sector interest underscores the versatility of Redwood's AI platform and its potential to support applications beyond potential pharmaceutical discovery, such as AI-enabled chemical intelligence workflows that integrate and combine multiple data sources, produce rapid predictive assessments of chemicals outside the lab environment, and support prioritization decisions by identifying compounds or materials that warrant additional review or laboratory validation.

The Company is actively exploring opportunities in the areas of defence and public safety, as interest continues to emerge. Redwood's platform combines AI-driven chemical synthesis design, predictive chemical analysis, and advanced data modeling capabilities that may be applicable to a broad range of additional use cases. These include areas such as chemical hazard detection, analysis of precursor chemical supply chains, and the accelerated development of medical countermeasures. While Redwood remains focused on advancing its core AI platform for pharmaceutical discovery, development and manufacturing, the Company believes these adjacent applications represent a natural extension of the same underlying technology. The Company notes that advancing these opportunities may require incremental platform enhancements, including domain-specific data integration and model tuning, consistent with the Company's ongoing development roadmap, but would not be expected to require the development of an entirely separate platform.

Redwood is evaluating these opportunities within the context of rapidly expanding global markets for artificial intelligence, advanced analytics, and next-generation computational technologies. Global defense spending is projected to exceed US$6.3 trillion by 2035 as governments increasingly integrate AI-driven analytics and advanced technologies into national security systems.¹ In this environment, Redwood believes its AI platform may be well positioned to enable innovation across multiple sectors while continuing to advance its focus on pharmaceutical discovery.

"What we are seeing is growing recognition that advanced chemical intelligence can support a wide range of real-world challenges. The same technology we are developing to accelerate potential drug discovery can also provide insights for areas such as chemical hazard analysis, preparedness initiatives, and emerging fields like quantum-enabled chemical modeling. As these conversations develop, we see opportunities to work with organizations across sectors including public safety, advanced research and certain defense-related applications," said Louis Dron, CEO of Redwood AI.

About Redwood AI Inc.

Redwood AI is a Vancouver-based artificial intelligence company providing software and analytics solutions for chemical development. Its platform integrates state-of-the-art AI models, cheminformatics, and operational data to support synthesis planning, process optimization, and supply-chain decision-making, helping reduce time, cost, and risk from early development through commercialization.

ON BEHALF OF REDWOOD AI CORP.,

"Louis Dron"
Chief Executive Officer

For more information, please contact:

Louis Dron
Chief Executive Officer
Tel: +1 888 530 8488
Email: [email protected]

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

Forward-Looking Statements Caution.

This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation, including, without limitation, statements regarding the potential for new industry engagements and opportunities and the Company's future goals and objectives. Generally, forward-looking information can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain acts, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved".

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information, including, without limitation, risks relating to the failure of new business opportunities to materials, the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company's strategy or expectations regarding its software will materialize as anticipated or at all. Accordingly, readers should not place undue reliance on any such forward-looking information.

Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

¹https://www.sphericalinsights.com/press-release/defence-spending-market
² https://www.mckinsey.com/capabilities/tech-and-ai/our-insights/the-year-of-quantum-from-concept-to-reality-in-2025

View the original press release on ACCESS Newswire

W.Nelson--AT